These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34171305)

  • 1. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
    Weingarten-Gabbay S; Klaeger S; Sarkizova S; Pearlman LR; Chen DY; Gallagher KME; Bauer MR; Taylor HB; Dunn WA; Tarr C; Sidney J; Rachimi S; Conway HL; Katsis K; Wang Y; Leistritz-Edwards D; Durkin MR; Tomkins-Tinch CH; Finkel Y; Nachshon A; Gentili M; Rivera KD; Carulli IP; Chea VA; Chandrashekar A; Bozkus CC; Carrington M; ; Bhardwaj N; Barouch DH; Sette A; Maus MV; Rice CM; Clauser KR; Keskin DB; Pregibon DC; Hacohen N; Carr SA; Abelin JG; Saeed M; Sabeti PC
    Cell; 2021 Jul; 184(15):3962-3980.e17. PubMed ID: 34171305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics.
    Nagler A; Kalaora S; Barbolin C; Gangaev A; Ketelaars SLC; Alon M; Pai J; Benedek G; Yahalom-Ronen Y; Erez N; Greenberg P; Yagel G; Peri A; Levin Y; Satpathy AT; Bar-Haim E; Paran N; Kvistborg P; Samuels Y
    Cell Rep; 2021 Jun; 35(13):109305. PubMed ID: 34166618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs.
    Weingarten-Gabbay S; Klaeger S; Sarkizova S; Pearlman LR; Chen DY; Bauer MR; Taylor HB; Conway HL; Tomkins-Tinch CH; Finkel Y; Nachshon A; Gentili M; Rivera KD; Keskin DB; Rice CM; Clauser KR; Hacohen N; Carr SA; Abelin JG; Saeed M; Sabeti PC
    bioRxiv; 2020 Oct; ():. PubMed ID: 33024965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.
    Parker R; Partridge T; Wormald C; Kawahara R; Stalls V; Aggelakopoulou M; Parker J; Powell Doherty R; Ariosa Morejon Y; Lee E; Saunders K; Haynes BF; Acharya P; Thaysen-Andersen M; Borrow P; Ternette N
    Cell Rep; 2021 May; 35(8):109179. PubMed ID: 34004174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HLA-II immunopeptidome of SARS-CoV-2.
    Weingarten-Gabbay S; Chen DY; Sarkizova S; Taylor HB; Gentili M; Hernandez GM; Pearlman LR; Bauer MR; Rice CM; Clauser KR; Hacohen N; Carr SA; Abelin JG; Saeed M; Sabeti PC
    Cell Rep; 2024 Jan; 43(1):113596. PubMed ID: 38117652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
    Nelde A; Bilich T; Heitmann JS; Maringer Y; Salih HR; Roerden M; Lübke M; Bauer J; Rieth J; Wacker M; Peter A; Hörber S; Traenkle B; Kaiser PD; Rothbauer U; Becker M; Junker D; Krause G; Strengert M; Schneiderhan-Marra N; Templin MF; Joos TO; Kowalewski DJ; Stos-Zweifel V; Fehr M; Rabsteyn A; Mirakaj V; Karbach J; Jäger E; Graf M; Gruber LC; Rachfalski D; Preuß B; Hagelstein I; Märklin M; Bakchoul T; Gouttefangeas C; Kohlbacher O; Klein R; Stevanović S; Rammensee HG; Walz JS
    Nat Immunol; 2021 Jan; 22(1):74-85. PubMed ID: 32999467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.
    Piadel K; Haybatollahi A; Dalgleish AG; Smith PL
    J Gen Virol; 2022 Jan; 103(1):. PubMed ID: 35014605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape and selection of vaccine epitopes in SARS-CoV-2.
    Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
    Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
    Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
    Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    PLoS Pathog; 2023 Jul; 19(7):e1011032. PubMed ID: 37498934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
    Nguyen A; David JK; Maden SK; Wood MA; Weeder BR; Nellore A; Thompson RF
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32303592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2.
    Kiyotani K; Toyoshima Y; Nemoto K; Nakamura Y
    J Hum Genet; 2020 Jul; 65(7):569-575. PubMed ID: 32372051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review.
    Abd El-Baky N; Amara AA; Redwan EM
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    bioRxiv; 2022 Dec; ():. PubMed ID: 36482973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
    Augusto DG; Murdolo LD; Chatzileontiadou DSM; Sabatino JJ; Yusufali T; Peyser ND; Butcher X; Kizer K; Guthrie K; Murray VW; Pae V; Sarvadhavabhatla S; Beltran F; Gill GS; Lynch KL; Yun C; Maguire CT; Peluso MJ; Hoh R; Henrich TJ; Deeks SG; Davidson M; Lu S; Goldberg SA; Kelly JD; Martin JN; Vierra-Green CA; Spellman SR; Langton DJ; Dewar-Oldis MJ; Smith C; Barnard PJ; Lee S; Marcus GM; Olgin JE; Pletcher MJ; Maiers M; Gras S; Hollenbach JA
    Nature; 2023 Aug; 620(7972):128-136. PubMed ID: 37468623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern.
    López D
    Front Immunol; 2022; 13():832889. PubMed ID: 35154154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.